Verastem Oncology Investors

16 investors on Angel Roster list Verastem Oncology in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Verastem Oncology can appear together.

Investors listed
16
With verified email
63%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Verastem Oncology investors

The most complete profiles first. Showing 16 of 16.

  • Christoph WestphalVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more

    Verified email available

  • Rich AldrichVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Bill WibergVerified

    Venture Capital · United States

    Health CareHospitalsE-commerceWomen Founded

    Portfolio: Zeltiq Aesthetics, Modria, Ardian, ChannelAdvisor and 43 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • David DonabedianVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • JOHN CLARKEVerified

    Micro VC · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Melinta, Cureatr, AxoGen, Verastem Oncology and 24 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Tom McKinleyVerified

    Micro VC · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Melinta, Cureatr, AxoGen, Verastem Oncology and 24 more

    Verified email available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Lea Hachigian

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Verastem Oncology investors are on Angel Roster?

Angel Roster lists 16 Verastem Oncology investors. 10 of them (63%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (14), Private Equity Firms (11) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Verastem Oncology investors invest in?

Among those that list a stage, the most common are Seed (4).

Where are Verastem Oncology investors based?

Most are based in the United States (16).

Which companies have Verastem Oncology investors backed?

The most-backed portfolio companies among them are Werewolf Therapeutics (13), Twentyeight-Seven Therapeutics (13), Mitobridge (13), Valeritas (10) and NeoVista (9).

How do I contact Verastem Oncology investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.